Spirulina platensis lacks antitumor effect against solid ehrlich carcinoma in female mice

Advances in Pharmacological Sciences

Volumn 2015, Issue , 2015, Pages

  Barakat, Waleed ^a,b   Elshazly, Shimaa M ^a   Mahmoud, Amr A A ^a  

^a Zagazig University   (Egypt)

^b UNIVERSITY OF TABUK   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; SPIRULINA EXTRACT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTHROSPIRA PLATENSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EHRLICH ASCITES TUMOR; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RANDOM SAMPLE;

EID: 84940784327     PISSN: 16876334     EISSN: 16876342     Source Type: Journal    
DOI: 10.1155/2015/132873     Document Type: Article

References (41)

1. A. A. Stavrovskaya, "Cellular mechanisms of multidrug resistance of tumor cells," Biochemistry, vol. 65, no. 1, pp. 95-106, 2000.
2. C. Moorthi, R. Manavalan, and K. Kathiresan, "Nano therapeutics to overcome conventional cancer chemotherapy limitations," Journal of Pharmacy and Pharmaceutical Sciences, vol. 14, no. 1, pp. 67-77, 2011.
3. G. M. Cragg and D. J. Newman, "Plants as a source of anticancer agents," Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 72-79, 2005.
4. D. J. Newman, G. M. Cragg, and K. M. Snader, "Natural products as sources of new drugs over the period 1981-2002," Journal of Natural Products, vol. 66, no. 7, pp. 1022-1037, 2003.
5. G. Chamorro, M. Salazar, L. Favila, and H. Bourges, "Pharmacology and toxicology of Spirulina alga," Revista de Investigación Clínica, vol. 48, no. 5, pp. 389-399, 1996.
6. J. E. Piero Estrada, P. Bermejo Bescós, and A. M. Villar del Fresno, "Antioxidant activity of different fractions of Spirulina platensis protean extract," Farmaco, vol. 56, no. 5-7, pp. 497-500, 2001.
7. C. Romay, J. Armesto, D. Remirez, R. González, N. Ledon, and I. García, "Antioxidant and anti-inflammatory properties of Cphycocyanin from blue-green algae," Inflammation Research, vol. 47, no. 1, pp. 36-41, 1998.
8. B. B. Vadiraja, N. W. Gaikwad, and K. M. Madyastha, "Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicty in rats," Biochemical and Biophysical Research Communications, vol. 249, no. 2, pp. 428-431, 1998.
9. K. R. Roy, K. M. Arunasree, N. P. Reddy, B. Dheeraj, G. V. Reddy, and P. Reddanna, "Alteration of mitochondrial membrane potential by Spirulina platensis C-phycocyanin induces apoptosis in the doxorubicinresistant human hepatocellularcarcinoma cell line HepG2," Biotechnology and Applied Biochemistry, vol. 47, no. 3, pp. 159-167, 2007.
10. T. Mishima, J. Murata, M. Toyoshima et al., "Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis," Clinical and Experimental Metastasis, vol. 16, no. 6, pp. 541-550, 1998.
11. J. Schwartz and G. Shklar, "Regression of experimental hamster cancer by beta carotene and algae extracts," Journal of Oral and Maxillofacial Surgery, vol. 45, no. 6, pp. 510-515, 1987.
12. M. F. Ismail, D. A. Ali, A. Fernando et al., "Chemoprevention of rat liver toxicity and carcinogenesis by Spirulina," International Journal of Biological Sciences, vol. 5, no. 4, pp. 377-387, 2009.
13. M. Ozaslan, I. D. Karagoz, I. H. Kilic, and M. E. Guldur, "Ehrlich ascites carcinoma," African Journal of Biotechnology, vol. 10, no. 13, pp. 2375-2378, 2011.
14. S. L. Da Silva, J. D. S. Chaar, and T. Yano, "Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae)," European Journal of Pharmacology, vol. 608, no. 1-3, pp. 76-83, 2009.
15. A. M. Kabel, M. N. Abdel-Rahman, A. E.-D. E. El-Sisi, M. S. Haleem, N. M. Ezzat, and M. A. El Rashidy, "Effect of atorvastatin and methotrexate on solid Ehrlich tumor," European Journal of Pharmacology, vol. 713, no. 1-3, pp. 47-53, 2013.
16. E. Noaman, N. K. Badr El-Din, M. A. Bibars, A. A. Abou Mossallam, and M. Ghoneum, "Antioxidant potential by arabinoxylan rice bran, MGN-3/biobran, represents a mechanism for its oncostatic effect againstmurine solid Ehrlich carcinoma," Cancer Letters, vol. 268, no. 2, pp. 348-359, 2008.
17. G. Chamorro-Cevallos, L. Garduño-Siciliano, B. L. Barrón, E. Madrigal-Bujaidar, D. E. Cruz-Vega, and N. Pages, "Chemoprotective effect of Spirulina (Arthrospira) against cyclophosphamide-induced mutagenicity in mice," Food and Chemical Toxicology, vol. 46, no. 2, pp. 567-574, 2008.
18. M. Mandal, S. K. Jaganathan, D. Mondhe, Z. A. Wani, and H. C. Pal, "Effect of honey and eugenol on ehrlich ascites and solid carcinoma," Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 989163, 5 pages, 2010.
19. D. A. Sorg and B. Buckner, "A simple method of obtaining venous blood from small laboratory animals," Proceedings of the Society for Experimental Biology and Medicine, vol. 115, pp. 1131-1132, 1964.
20. B. Fisher, J. Bryant, N. Wolmark et al., "Effect of preoperative chemotherapy on the outcome of women with operable breast cancer," Journal of Clinical Oncology, vol. 16, no. 8, pp. 2672-2685, 1998.
21. D. Mauri, N. Pavlidis, and J. P. A. Ioannidis, "Neoadjuvant versus adjuvant systemic treatment in breast cancer: a metaanalysis," Journal of the National Cancer Institute, vol. 97, no. 3, pp. 188-194, 2005.
22. S. Coseri, "Natural products and their analogues as efficient anticancer drugs," Mini-Reviews in Medicinal Chemistry, vol. 9, no. 5, pp. 560-571, 2009.
23. D. J. Newman, "Natural products as leads to potential drugs: an old process or the new hope for drug discovery?" Journal of Medicinal Chemistry, vol. 51, no. 9, pp. 2589-2599, 2008.
24. J. C. Dillon, A. P. Phuc, and J. P. Dubacq, "Nutritional value of the alga Spirulina," World Review of Nutrition and Dietetics, vol. 77, pp. 32-46, 1995.
25. V. B. Bhat and K. M. Madyastha, "C-Phycocyanin: a potent peroxyl radical scavenger in vivo and in vitro," Biochemical and Biophysical Research Communications, vol. 275, no. 1, pp. 20-25, 2000.
26. J. Subhashini, S. V. K. Mahipal, M. C. Reddy, M. M. Reddy, A. Rachamallu, and P. Reddanna, "Molecular mechanisms in C-Phycocyanin induced apoptosis in human chronic myeloid leukemia cell line-K562," Biochemical Pharmacology, vol. 68, no. 3, pp. 453-462, 2004.
27. A. El-Moneim Mahmoud Osman, M. M. Sayed Ahmed, M. T. El-Din Khayyal, and M. M. El-Merzabani, "Hyperthermic potentiation of cisplatin cytotoxicity on solid Ehrlich carcinoma," Tumori, vol. 79, no. 4, pp. 268-272, 1993.
28. R. Kapoor and U. Mehta, "Utilization of β-carotene from Spirulina platensis by rats," Plant Foods for Human Nutrition, vol. 43, no. 1, pp. 1-7, 1993.
29. G. V. Mitchell, E. Grundel, M. Jenkins, and S. R. Blakely, "Effects of graded dietary levels of spirulina maxima on vitamins A and E in male rats," Journal of Nutrition, vol. 120, no. 10, pp. 1235-1240, 1990.
30. V. Annapurna, N. Shah, P. Bhaskaram, M. S. Bamji, and V. Reddy, "Bioavailability of spirulina carotenes in preschool children," Journal of Clinical Biochemistry and Nutrition, vol. 10, no. 2, pp. 145-151, 1991.
31. P. E. Johnson and L. E. Shubert, "Availability of iron to rats from spirulina, a blue-green alga," Nutrition Research, vol. 6, no. 1, pp. 85-94, 1986.
32. C. Santillan, "Cultivation of the Spirulina for human consumption and for animal feed," in Proceedings of the International Congress of Food Science and Technology, Madrid, Spain, September 1974.
33. F. Yogianti, M. Kunisada, E. Nakano et al., "Inhibitory effects of dietary Spirulina platensis on UVB-induced skin inflammatory responses and carcinogenesis," Journal of Investigative Dermatology, vol. 134, pp. 2610-2619, 2014.
34. A. Ouhtit, M. F. Ismail, A. Othman et al., "Chemo prevention of rat mammary carcinogenesis by spirulina," The American Journal of Pathology, vol. 184, no. 1, pp. 296-303, 2014.
35. O. Trédan, C. M. Galmarini, K. Patel, and I. F. Tannock, "Drug resistance and the solid tumor microenvironment," Journal of the National Cancer Institute, vol. 99, no. 19, pp. 1441-1454, 2007.
36. A. Polk, M. Vaage-Nilsen, K. Vistisen, and D. L. Nielsen, Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors," Cancer Treatment Reviews, vol. 39, no. 8, pp. 974-984, 2013.
37. W. J. Gradishar and E. E. Vokes, "5-fluorouracil cardiotoxicity: a critical review," Annals of Oncology, vol. 1, no. 6, pp. 409-414, 1990.
38. A. A. Jakubowski and N. Kemeny, "Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil," Cancer, vol. 62, no. 2, pp. 266-269, 1988.
39. G. Hsiao, P. O.-H. Chou, M.-Y. Shen, D.-S. Chou, C.-H. Lin, and J.-R. Sheu, "C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis," Journal of Agricultural and Food Chemistry, vol. 53, no. 20, pp. 7734-7740, 2005.
40. R. B. Diasio and B. E. Harris, "Clinical pharmacology of 5-fluorouracil," Clinical Pharmacokinetics, vol. 16, no. 4, pp. 215-237, 1989.
41. S. Savranoglu and T. B. Tumer, "Inhibitory effects of spirulina platensis on carcinogen-activating cytochrome P450 isozymes and potential for drug interactions," International Journal of Toxicology, vol. 32, no. 5, pp. 376-384, 2013.